Why the study?
Does endomyocardial biopsy guide appropriate immunosuppressive therapy in patients with a new onset of unexplained congestive heart failure?
Does endomyocardial biopsy guide appropriate immunosuppressive therapy in patients with a new onset of unexplained congestive heart failure?
Discusses the role of endomyocardial biopsy in identifying patients with unexplained heart failure who might benefit from immunosuppressive therapy.
Answers are grounded in this paper and cite their sources.
Endomyocardial biopsy may guide immunosuppression in select unexplained HF; leaves open need for prospective validation before routine adoption.
Some investigators have advocated endomyocardial biopsy for patients with a new onset of unexplained congestive heart failure. The rationale is that immunosuppressive therapy might be appropriate for a subset of patients with biopsy-proven …
No takes yet. Share an insight, caveat, or question.
Asb (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: